October's Top Growth Stocks: No-Brainer Buys with Potential Soar
October historically tends to be a good month for stocks, and three growth stocks stand out as top buys for the final quarter of 2023: CRISPR Therapeutics, DraftKings, and Roivant Sciences. CRISPR Therapeutics is on the verge of making history with its CRISPR/Cas9 gene-edited sickle cell disease candidate, and its broad pipeline of candidates holds potential for treating various ailments. DraftKings, despite still losing money, has seen its stock soar due to its ability to grow revenue in the online gaming and sports-betting industry. Roivant Sciences, with its unique business strategy and two blockbuster immunology drugs, offers a compelling value proposition for investors.
- 3 No-Brainer Growth Stocks to Buy in October The Motley Fool
- Top Growth Stocks for October 2023 Investopedia
- 3 Stocks to Buy in October That Could Soar More Than 40% Over the Next 12 Months, According to Wall Street The Motley Fool
- October forex seasonals: No help for bonds but the mood tends to improve ForexLive
Reading Insights
0
1
4 min
vs 5 min read
89%
910 → 103 words
Want the full story? Read the original article
Read on The Motley Fool